Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Hendlisz

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Current Opinion in Oncology|May 11, 2018
The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategiesEdouard Massaut, Ali Bohlok, Valerio Lucidi, et al.
Cancer Treatment Reviews|September 4, 2022
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancerTugba Akin Telli, Giacomo Bregni, Michele Vanhooren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal CancerErwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Physics in Medicine and Biology|November 4, 2008
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheresPatrick Flamen, Bruno Vanderlinden, Philippe Delatte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal CancerErwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2012
Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancerIrène Buvat, Hatem Necib, Camilo Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2011
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imagingHatem Necib, Camilo Garcia, Antoine Wagner, et al.
BMJ Open|March 11, 2015
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocolAlain Hendlisz, Amélie Deleporte, Caroline Vandeputte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapyJacques-Antoine Maisonobe, Camilo A Garcia, Hatem Necib, et al.
Acta Gastro-Enterologica Belgica|February 10, 2009
Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literatureBertrand Vos, Julien Gallez, Sébastien Debroux, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Current Opinion in Oncology|May 11, 2018
The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategiesEdouard Massaut, Ali Bohlok, Valerio Lucidi, et al.
Cancer Treatment Reviews|September 4, 2022
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancerTugba Akin Telli, Giacomo Bregni, Michele Vanhooren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Combining <sup>18</sup>F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal CancerErwin Woff, Pashalina Kehagias, Caroline Vandeputte, et al.
Physics in Medicine and Biology|November 4, 2008
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheresPatrick Flamen, Bruno Vanderlinden, Philippe Delatte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2018
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal CancerErwin Woff, Alain Hendlisz, Lieveke Ameye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 20, 2012
Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancerIrène Buvat, Hatem Necib, Camilo Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2011
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imagingHatem Necib, Camilo Garcia, Antoine Wagner, et al.
BMJ Open|March 11, 2015
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocolAlain Hendlisz, Amélie Deleporte, Caroline Vandeputte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapyJacques-Antoine Maisonobe, Camilo A Garcia, Hatem Necib, et al.
Acta Gastro-Enterologica Belgica|February 10, 2009
Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literatureBertrand Vos, Julien Gallez, Sébastien Debroux, et al.
Pageof 14